pl
en
Country
pl
Language
en

Treatment of CRPC patients with abiraterone acetate within the National Health Fund's medication program

Speciality: Oncology
Language : Polski
Broadcast type : Live conference
Duration : 00:11:21
Date: May 26, 2014

Only one medication program is available for CRPC patients. However, some issues can be unclear or ambiguous. Prof. Piotr Wysocki explains how to interpret its individual records.

Other in: Oncology